| |
|
|
|
Acasti Pharma  
|
|
2.19 0.02 (0.01%) |
09-17 16:00 |
|
Open: |
2.14 |
Pre close: |
2.17 |
Target:
|
3.71
|
|
High: |
2.2192 |
Low: |
2.14 |
Resistance:
|
3.18
3.84
|
|
Volume: |
416,988 |
Market Cap: |
97M |
Support:
|
2.11
1.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.24
 |
MACD |
MACD(12,26):
|
-0.38  |
|
MA(20): |
2.73 |
Signal(12,26,9): |
-0.36 |
|
MA(100): |
3.76 |
Stochastic Oscillator |
%K(14,3):
|
4.42 |
|
MA(250): |
3.74 |
%D(3): |
5.22 |
|
Average Volume(K) |
3-Month: |
105470
|
52-Week |
High:
|
9.76 |
|
10-Days: |
106991 |
Low: |
1.36 |
|
RSI |
RSI(14):
|
29.32 |
Change(%): |
-2.2 |
|
Financials, Statistics and Valuation |
|
EPS |
0.027 |
Return on Equity (ttm) |
24.7 |
Shares Out. (M) |
200.12 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-28.3 |
Shares Float (M) |
179.14 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
2.21 |
|
Forward EPS |
-0.714 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2980 |
|
Book Value (p.s.) |
0.170 |
EBITDA (p.s.) |
-0.061 |
P/E |
81.11 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
12.88 |
|
Profit Margin |
3188.89 |
Operating Cash Flow
(M) |
-15.45 |
P/S |
5410.65 |
|
Operating Margin |
-16851.85 |
Levered Free Cash Flow
(M) |
-12.24 |
P/CF |
-28.37 |
|
|
|
|
|
|
